Twist Bioscience (TWST) Retained Earnings (2018 - 2026)

Twist Bioscience (TWST) has reported Retained Earnings for 9 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 5.87% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 5.87% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 4.55% from the prior year.
• Retained Earnings was $1.9 billion for Q2 2026 at Twist Bioscience, up from $1.8 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $1.9 billion in Q2 2026 and troughed at $1.6 billion in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings jumped 38.25% in 2022 and grew 2.32% in 2023, its largest moves.
• Over 5 years, Retained Earnings stood at $1.6 billion in 2022, then gained by 3.07% to $1.7 billion in 2023, then climbed by 3.8% to $1.7 billion in 2024, then rose by 4.43% to $1.8 billion in 2025, then gained by 3.81% to $1.9 billion in 2026.
• The last three Retained Earnings figures came in at $1.9 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.